Celldex Therapeutics Inc · Cash & Short-Term Investments

Latest reported$518.57Mperiod endingDec 31, 2025

CLDX FY Cash & Short-Term Investments ($2.40M → $518.57M)

Annual Cash & Short-Term Investments

High-resolution chart · PNG

CLDX cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Celldex Therapeutics Inc Cash & Short-Term Investments — Annual fiscal periods (USD)
Period ending	Cash & Short-Term Investments (USD)
Dec 31, 2025	518,573,000
Dec 31, 2024	725,281,000
Dec 31, 2023	421,698,000
Dec 31, 2022	304,952,000
Dec 31, 2021	408,250,000
Dec 31, 2020	194,422,000
Dec 31, 2019	64,183,000
Dec 31, 2018	94,022,000
Dec 31, 2017	139,427,000
Dec 31, 2016	189,776,000
Dec 31, 2015	289,889,000
Dec 31, 2014	201,043,000
Dec 31, 2013	302,983,000
Dec 31, 2012	83,962,000
Dec 31, 2011	53,312,000
Dec 31, 2010	61,098,000
Dec 31, 2009	82,453,000
Dec 31, 2008	44,257,286
Dec 31, 2007	4,909,530
Dec 31, 2006	40,911,539
Dec 31, 2005	23,419,434
Dec 31, 2004	31,741,500
Dec 31, 2003	20,251,000
Dec 31, 2002	25,070,700
Dec 31, 2001	42,665,900
Dec 31, 2000	50,177,000
Dec 31, 1999	13,619,000
Dec 31, 1998	8,900,000
Dec 31, 1997	6,400,000
Dec 31, 1996	12,600,000
Dec 31, 1995	12,300,000
Dec 31, 1994	7,600,000
Dec 31, 1993	28,300,000
Dec 31, 1992	3,300,000
Apr 30, 1992	8,700,000
Apr 30, 1990	11,300,000
Apr 30, 1989	9,600,000
Apr 30, 1988	10,800,000
Apr 30, 1987	13,500,000
Apr 30, 1986	2,400,000